Anil Sukumaran FDS RCPS (Royal College of Physicians and Surgeons of Glasgow); PhD (University of Hong Kong)
Professor, Senior Consultant, Hamad Medical Corporation, DOHA · Qatar
Editorial leadership for Journal of Biomaterials
Research interests
- Implant Dentistry
- Periodontics
Biography
Dr. Anil Sukumaran, PhD, is a Professor and Senior Consultant at Hamad Medical Corporation in Doha, Qatar, with specialized expertise in implant dentistry and periodontics. He received his education from the Royal College of Physicians and Surgeons of Glasgow and the University of Hong Kong. Dr. Sukumaran has authored over 52 indexed publications spanning diverse research areas, including bone morphology around dental implants, biomaterial development, endodontic irrigation systems, and the therapeutic applications of marine-derived proteins and polysaccharides. His most-cited work, "Marine Fish Proteins and Peptides for Cosmeceuticals: A Review" (2017), has garnered 233 citations, reflecting his contributions to translational research bridging dentistry, regenerative medicine, and biomaterials science.
Selected publications
- Marine Fish Proteins and Peptides for Cosmeceuticals: A Review 2017 cited 233×
- Seaweed Polysaccharide-Based Nanoparticles: Preparation and Applications for Drug Delivery 2016 cited 189×
- Isolation and Characterization of Nano-Hydroxyapatite from Salmon Fish Bone 2015 cited 120×
- Preparation, Characterization and Biological Applications of Biosynthesized Silver Nanoparticles with Chitosan-Fucoidan Coating 2018 cited 83×
- A case‐control study on the association between periodontitis and coronavirus disease (COVID‐19) 2021 cited 83×
- Nano-Hydroxyapatite (nHAp) in the Remineralization of Early Dental Caries: A Scoping Review 2022 cited 72×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JBI for your work?
This journal is guided by Anil Sukumaran (Professor, Senior Consultant, Hamad Medical Corporation, DOHA) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.